LASSBio 596 per os avoids pulmonary and hepatic inflammation induced by microcystin-LR

► LASSBio 596 was tested for the first time by oral administration. ► LASSBio 596 per os avoided lung inflammation and pulmonary mechanical dysfunction. ► LASSBio 596 per os improved liver structure and inflammation.